Note*: This report requires 7-10 business days to complete.
DelveInsight’s Nasopharyngeal Cancer - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Crohn’s disease for the seven major markets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Nasopharyngeal Cancer forecasted market share for ten years to 2023 segmented by seven major markets. In addition, the report also includes global forecast of epidemiology of Nasopharyngeal Cancer till 2023.
Key Coverage and Benefits
• The report will help in developing business strategies by understanding the trends shaping and driving the global Nasopharyngeal Cancer market.
• Identifying patient populations in the global “Nasopharyngeal Cancermarket to improve product design, pricing, and launch plans.
• Organize sales and marketing efforts by identifying the best opportunities for Nasopharyngeal Cancer therapeutics in each of the markets covered.
• To understand the future market competition in the global Nasopharyngeal Cancer therapeutics market and Insightful review of the key market drivers and barriers.
Scope
• Report covers the disease overview including etiology, path physiology, symptoms, diagnosis, disease management, and current treatment options.
• Marketed information including available prescription drugs, its patent and exclusivity details followed by drug sales till 2018.
• The Report also covers the detailed global historical and forecasted epidemiological data covering United States, EU5, Japan and rest of the word from 2013-2023.
• It also provides Nasopharyngeal Cancer for United States, EU5 and Japan from 2013 and forecasted Market to 2023.
'
Table of Contents
• Nasopharyngeal Cancer overview
• Pathophysiology
• Symptoms of disease
• Etiology of disease
• Diagnosis of disease
• Treatment of disease
• Overview of Marketed drugs
• Drug Description
• Mechanism of Action
• Pharmacokinetics Properties
• Marketed Details
• Patent Information
• Patent Exclusivity Expiry Assessment United States (US)
• Patents Details
• Historical and Forecasted sales of marketed molecules in the Global Nasopharyngeal Cancer Market
• Global Epidemiology of Nasopharyngeal Cancer Forecasted to 2023
• Global Market (2013-2015)
• Global Forecasted Market (2016-2023)
• Global Market by Geography
• Market of US (2013-2015)
• Forecasted Market of US (2016-2023)
• Market of Europe
• Market of Germany (2013-2015)
• Forecasted Market of Germany (2016-2023)
• Market of United Kingdom (2013-2015)
• Forecasted Market of United Kingdom (2016-2023)
• Market of France (2013-2015)
• Forecasted Market of France (2016-2023)
• Market of Italy (2013-2015)
• Forecasted Market of Italy (2016-2023)
• Market of Spain (2013-2015)
• Forecasted Market of Spain (2016-2023)
• Market of Japan (2013-2015)
• Forecasted Market of Japan (2016-2023)
• Market of ROW (2013-2015)
• Forecasted Market of ROW (2016-2023)
• Appendix
• Report Methodology
• Consulting Services
• Disclaimer
• Report Purchase Options
• About DelveInsight
List of Tables
• Table 1: Drug Description
• Table 2: Drug, Marketed Details United States (US)
• Table 3: Drug, Patent Number Specific Patent Expiry in US (Year), 2015
• Table 4: Drug, Patent Details for US
• Table 5: Nasopharyngeal Cancer Drug Sales (USD Millions)-2023
• Table 6: Global Epidemiology of Nasopharyngeal Cancer (2013-2023)
• Table 7: Nasopharyngeal Cancer Global Market (USD Millions), (2013-2015)
• Table 8: Nasopharyngeal Cancer Global Market (USD Millions), (2016-2023)
• Table 9: Nasopharyngeal Cancer US Market (USD Millions), (2013-2015)
• Table 10: Nasopharyngeal Cancer US Market (USD Millions), (2016-2023)
• Table 11: Nasopharyngeal Cancer Germany Market (USD Millions), (2013-2015)
• Table 12: Nasopharyngeal Cancer Germany Market (USD Millions), (2016-2023)
• Table 13: Nasopharyngeal Cancer United Kingdom Market (USD Millions), (2013-2015)
• Table 14: Nasopharyngeal Cancer United Kingdom Market (USD Millions), (2016-2023)
• Table 15: Nasopharyngeal Cancer France Market (USD Millions), (2013-2015)
• Table 16: Nasopharyngeal Cancer France Market (USD Millions), (2016-2023)
• Table 17: Nasopharyngeal Cancer Italy Market (USD Millions), (2013-2015)
• Table 18: Nasopharyngeal Cancer Italy Market (USD Millions), (2016-2023)
• Table 19: Nasopharyngeal Cancer Spain Market (USD Millions), (2013-2015)
• Table 20: Nasopharyngeal Cancer Spain Market (USD Millions), (2016-2023)
• Table 21: Nasopharyngeal Cancer Japan Market (USD Millions), (2013-2015)
• Table 22: Nasopharyngeal Cancer Japan Market (USD Millions), (2016-2023)
• Table 23: Nasopharyngeal Cancer ROW Market (USD Millions), (2013-2015)
• Table 24: Nasopharyngeal Cancer ROW Market (USD Millions), (2016-2023)
List of Figures
• Figure 1: Nasopharyngeal Cancer Drug Sales (USD Millions)-2023
• Figure 2: Global Epidemiology of Nasopharyngeal Cancer (2013-2023)
• Figure 3: Nasopharyngeal Cancer Global Market (USD Millions), (2013-2015)
• Figure 4: Nasopharyngeal Cancer Global Market (USD Millions), (2016-2023)
• Figure 5: Nasopharyngeal Cancer US Market (USD Millions), (2013-2015)
• Figure 6: Nasopharyngeal Cancer US Market (USD Millions), (2016-2023)
• Figure 7: Nasopharyngeal Cancer Germany Market (USD Millions), (2013-2015)
• Figure 8: Nasopharyngeal Cancer Germany Market (USD Millions), (2016-2023)
• Figure 9: Nasopharyngeal Cancer United Kingdom Market (USD Millions), (2013-2015)
• Figure 10: Nasopharyngeal Cancer United Kingdom Market (USD Millions), (2016-2023)
• Figure 11: Nasopharyngeal Cancer France Market (USD Millions), (2013-2015)
• Figure 12: Nasopharyngeal Cancer France Market (USD Millions), (2016-2023)
• Figure 13: Nasopharyngeal Cancer Italy Market (USD Millions), (2013-2015)
• Figure 14: Nasopharyngeal Cancer Italy Market (USD Millions), (2016-2023)
• Figure 15: Nasopharyngeal Cancer Spain Market (USD Millions), (2013-2015)
• Figure 16: Nasopharyngeal Cancer Spain Market (USD Millions), (2016-2023)
• Figure 17: Nasopharyngeal Cancer Japan Market (USD Millions), (2013-2015)
• Figure 18: Nasopharyngeal Cancer Japan Market (USD Millions), (2015-2023)
• Figure 19: Nasopharyngeal Cancer ROW Market (USD Millions), (2013-2015)
• Figure 20: Nasopharyngeal Cancer ROW Market (USD Millions), (2016-2023)
• Ambrx Inc.
• AVEO Pharmaceuticals Inc.
• Biomics Biotechnologies Co. Ltd.
• Celgene Corporation
• Cell Medica Limited
• F. Hoffmann-La Roche Ltd.
• GlaxoSmithKline Plc
• Merck & Co. Inc.
• Molecular Partners AG
• Ono Pharmaceutical Co. Ltd.
• Pharmacyclics Inc.
• Sapvax
• Shenzen SiBiono GeneTech Co. Ltd
• Theravectys SA
